- Home
- LOT vs EWTX Comparison
LOT vs EWTX Comparison
Compare LOT & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOT
- EWTX
- Stock Information
- Founded
- LOT 1948
- EWTX 2017
- Country
- LOT China
- EWTX United States
- Employees
- LOT N/A
- EWTX N/A
- Industry
- LOT
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- LOT
- EWTX Health Care
- Exchange
- LOT NYSE
- EWTX Nasdaq
- Market Cap
- LOT 2.3B
- EWTX 2.7B
- IPO Year
- LOT N/A
- EWTX 2021
- Fundamental
- Price
- LOT $3.48
- EWTX $30.11
- Analyst Decision
- LOT
- EWTX Buy
- Analyst Count
- LOT 0
- EWTX 6
- Target Price
- LOT N/A
- EWTX $44.83
- AVG Volume (30 Days)
- LOT 151.3K
- EWTX 762.1K
- Earning Date
- LOT 11-21-2024
- EWTX 11-07-2024
- Dividend Yield
- LOT N/A
- EWTX N/A
- EPS Growth
- LOT N/A
- EWTX N/A
- EPS
- LOT N/A
- EWTX N/A
- Revenue
- LOT $1,013,890,000.00
- EWTX N/A
- Revenue This Year
- LOT $61.26
- EWTX N/A
- Revenue Next Year
- LOT $62.92
- EWTX N/A
- P/E Ratio
- LOT N/A
- EWTX N/A
- Revenue Growth
- LOT 213.08
- EWTX N/A
- 52 Week Low
- LOT $3.15
- EWTX $8.00
- 52 Week High
- LOT $17.99
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- LOT 36.31
- EWTX 46.80
- Support Level
- LOT $3.15
- EWTX $27.00
- Resistance Level
- LOT $3.60
- EWTX $35.50
- Average True Range (ATR)
- LOT 0.27
- EWTX 2.36
- MACD
- LOT -0.03
- EWTX -0.10
- Stochastic Oscillator
- LOT 33.85
- EWTX 38.94
About LOT LOTUS TECHNOLOGY INC
Lotus Technology Inc is a battery electric vehicle (BEV) maker that designs, develops, and sells BEV lifestyle vehicles under the Lotus brand. The Group is also a distributor that sells luxury sports cars under the Lotus brand. It also provides other sales and ancillary services to customers.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.